<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The peroxisome proliferator-activated receptor gamma co-activator 1alpha (<z:chebi fb="6" ids="26336">PGC</z:chebi>-1alpha) is a novel transcriptional co-activator that holds an important role in <z:chebi fb="23" ids="18059">lipid</z:chebi> and <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="6" ids="26336">PGC</z:chebi>-1alpha is a candidate gene for the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (MS) as well as type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Recent studies suggested linkage between the chromosomal region of <z:chebi fb="6" ids="26336">PGC</z:chebi>-1alpha and fasting serum insulin levels, and associates a Gly482Ser polymorphism of the gene with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we investigated whether the Gly482Ser variant is associated with the MS per se or other phenotypic traits related to this syndrome </plain></SENT>
<SENT sid="4" pm="."><plain>The variant was examined, using PCR-RFLP, in the DanMONICA cohort comprising a population-based sample of 2349 subjects </plain></SENT>
<SENT sid="5" pm="."><plain>MS was defined using the National Cholesterol Education Program -- Adult Treatment Panel III (NCEP-ATPIII) criteria </plain></SENT>
<SENT sid="6" pm="."><plain>The allelic frequency of the Ser482 allele was 35.8% in the MS group and 35.6% in the non-MS group (P = 0.74) </plain></SENT>
<SENT sid="7" pm="."><plain>There were no significant differences across the three groups of genotypes with respect to any of the examined variables, including BMI, waist, fasting serum <z:chebi fb="23" ids="18059">lipids</z:chebi>, plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, serum insulin, HOMA estimates of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and insulin secretion, 24-ambulatory blood pressure or left ventricular mass index </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, the Gly482Ser polymorphism of the <z:chebi fb="6" ids="26336">PGC</z:chebi>-1alpha gene is not associated with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, related quantitative traits or <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp> among Danish Caucasian subjects </plain></SENT>
</text></document>